Pharmaceutical Care for One Case of Severe Brain Injury with Infection after Decompressive Craniotomy
- VernacularTitle:1例重型颅脑损伤术后感染患者的药学监护
- Author:
Jia LIHUA
;
Li YONG
- Publication Type:Journal Article
- Keywords:
Clinical pharmacists;
Severe brain injury;
Intracranial infection;
Pharmaceutical care
- From:
China Pharmacist
2015;18(12):2126-2129
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the participation mode of clinical pharmacists in anti-infective therapy. Methods:Clinical phar-macists provided rational medication suggestions for anti-bacterial and antifungal therapy, and carried out pharmaceutical care for one patient with lung and intracranial infection after decompressive craniotomy for severe brain injury. Results: According to the sugges-tions of clinical pharmacists, fluconazole therapeutic regimen and amphotericin B therapeutic regimen was applied in turn respectively with the treatment course of 32d and 28d. During the treatment, the pharmacists also provided therapy advice on the infection induced by Staphylococcus epidermidis and Pseudomonas stutzeri, ADR warning and monitoring of fluconazole and amphotericin B, and adjust-ment of anti-infective therapy according to the results of antimicrobial susceptibility testing. The therapeutic effect was significant. Conclusion:The participation of clinical pharmacists in drug treatment can optimize medical therapy, which contributes to the coopera-tion between doctors and pharmacists.
